Ethical Issues in Use of Medications During Lactation

Abbasi M. Majdzadeh R. Zali A. Karimi A. Akrami F. (2018). The evolution of public health ethics frameworks: Systematic review of moral values and norms in public health policy. Medicine, Health Care and Philosophy, 21(3), 387–402. https://doi.org/10.1007/s11019-017-9813-y

Amir L. H. Ryan K. M. Jordan S. E. (2012). Avoiding risk at what cost? Putting use of medicines for breastfeeding women into perspective. International Breastfeeding Journal, 7, 14. https://doi.org/10.1186/1746-4358-7-14

BBMRI-ERIC. (2019). Launch of ConcePTION, an EU project setting standards for research on pregnant and breastfeeding women. http://www.bbmri-eric.eu/news-events/launch-of-conception-an-eu-project-setting-standards-for-research-on-pregnant-and-breastfeeding-women/

Beauchamp T. L. Childress J. F. (2013). Principles of biomedical ethics (7th ed.). New York, NY: Oxford University Press.

Byrne J. J. Spong C. Y. (2019). “Is it safe?” The many unanswered questions about medications and breast-feeding. New England Journal of Medicine, 380(14), 1296–1297. https://doi.org/10.1056/NEJMp1817420

Carpenter D. Gonzalez D. Retsch-Bogart G. Sleath B. Wilfond B. (2017). Methodological and ethical issues in pediatric medication safety research. Pediatrics, 140(3), e20170195. https://doi.org/10.1542/peds.2017-0195

Cobb B. Liu R. Valentine E. Onuoha O. (2015). Breastfeeding after anesthesia: A review for anesthesia providers regarding the transfer of medications into breast milk. Translational Perioperative and Pain Medicine, 1(2), 1–7.

Cornelison T. L. Clayton J. A. (2017). Considering sex as a biological variable in biomedical research. Gender and the Genome, 1(2). https://doi.org/10.1089/gg.2017.0006

Davanzo R. Bua J. De Cunto A. Farina M. L. De Ponti F. Clavenna A. . . . Clementi M. (2016). Advising mothers on the use of medications during breastfeeding: A need for a positive attitude. Journal of Human Lactation, 32(1), 15–19. https://doi.org/10.1177/0890334415595513

Delaney S. R. Malik P. R. V. Stefan C. Edginton A. N. Colantonio D. A. Ito S. (2018). Predicting escitalopram exposure to breastfeeding infants: Integrating analytical and in silico techniques. Clinical Pharmacokinetics, 57(12), 1603–1611. https://doi.org/10.1007/s40262-018-0657-2

Franconi F. Campesi I. Colombo D. Antonini P. (2019). Sex-gender variable: Methodological recommendations for increasing scientific value of clinical studies. Cells, 8(5). https://doi.org/10.3390/cells8050476

Frattarelli D. A. Galinkin J. L. Green T. P. Johnson T. D. Neville K. A. Paul I. M. , . . . American Academy of Pediatrics Committee on Drugs. (2014). Off-label use of drugs in children. Pediatrics, 133(3), 563–567. https://doi.org/10.1542/peds.2013-4060

Golden S. D. Earp J. A. (2012). Social ecological approaches to individuals and their contexts: twenty years of health education and behavior health promotion interventions. Health Education & Behavior, 39(3), 364–372. https://doi.org/10.1177/1090198111418634

Gopichandran V. Luyckx V. A. Biller-Andorno N. Fairchild A. Singh J. Tran N. . . . Vahedi M. (2016). Developing the ethics of implementation research in health. Implementation Science, 11, 161. https://doi.org/10.1186/s13012-016-0527-y

Grzeskowiak L. E. Mol B. W. (2015). Off-label prescribing in pregnancy: A case of risky business or business as usual? European Journal of Obstetrics & Gynecology and Reproductive Biology, 187, 78–79. https://doi.org/10.1016/j.ejogrb.2015.01.001

Hoffman E. Wald J. Colquhoun H. (2019). Evaluation of breast milk concentrations following brexanolone IV administration to healthy lactating women. American Journal of Obstetrics & Gynecology, 220, S554. https://doi.org/10.1016/j.ajog.2018.11.873

Krubiner C. B. Faden R. R. Karron R. A. Little M. O. Lyerly A. D. Abramson J. S. . . . PREVENT Working Group. (2019). Pregnant women and vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response. Vaccine. Advance online publication. https://doi.org/10.1016/j.vaccine.2019.01.011

Lyerly A. D. Faden R. R. (2013). Mothers matter: Ethics and research during pregnancy. Virtual Mentor, 15(9), 775–778. https://doi.org/10.1001/virtualmentor.2013.15.9.pfor1-1309

Matro R. Martin C. F. Wolf D. Shah S. A. Mahadevan U. (2018). Exposure concentrations of infants breastfed by women receiving biologic therapies for inflammatory bowel diseases and effects of breastfeeding on infections and development. Gastroenterology, 155(3), 696–704. https://doi.org/10.1053/j.gastro.2018.05.040

Mayo Clinic. (2019). Escitalopram (oral route). https://www.mayoclinic.org/drugs-supplements/escitalopram-oral-route/description/drg-20063707

McClatchey A. K. Shield A. Cheong L. H. Ferguson S. L. Cooper G. M. Kyle G. J. (2018). Why does the need for medication become a barrier to breastfeeding? A narrative review. Women and Birth, 31(5), 362–366. https://doi.org/10.1016/j.wombi.2017.12.004

McCormack J. Elwyn G. (2018). Shared decision is the only outcome that matters when it comes to evaluating evidence-based practice. BMJ Evidence-Based Medicine, 23(4), 137–139. https://doi.org/10.1136/bmjebm-2018-110922

McLeroy K. R. Bibeau D. Steckler A. Glanz K. (1988). An ecological perspective on health promotion programs. Health Education Quarterly, 15(4), 351–377. https://doi.org/10.1177/109019818801500401

Meltzer-Brody S. Colquhoun H. Riesenberg R. Epperson C. N. Deligiannidis K. M. Rubinow D. R. . . . Kanes S. (2018). Brexanolone injection in post-partum depression: Two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. The Lancet, 392(10152), 1058–1070. https://doi.org/10.1016/S0140-6736(18)31551-4

Newmark R. L. Bogen D. L. Wisner K. L. Isaac M. Ciolino J. D. Clark C. T. (2019). Risk-benefit assessment of infant exposure to lithium through breast milk: A systematic review of the literature. International Review of Psychiatry, 31(3), 295–304. https://doi.org/10.1080/09540261.2019.1586657

Ntali S. Damjanov N. Drakakis P. Ionescu R. Kalinova D. Rashkov R. . . . Boumpas D. T. (2014). Women’s health and fertility, family planning and pregnancy in immune-mediated rheumatic diseases: A report from a south-eastern European expert meeting. Clinical and Experimental Rheumatology, 32(6), 959–968.

Paul C. Zenut M. Dorut A. Coudore M. A. Vein J. Cardot J. M. Balayssac D. (2015). Use of domperidone as a galactagogue drug: A systematic review of the benefit-risk ratio. Journal of Human Lactation, 31(1), 57–63. https://doi.org/10.1177/0890334414561265

Rowe H. Baker T. Hale T. W. (2013). Maternal medication, drug use, and breastfeeding. Pediatric Clinics of North America, 60(1), 275–294. https://doi.org/10.1016/j.pcl.2012.10.009.

Saint-Raymond A. de Vries C. S. (2016). Medicine safety in pregnancy and ambitions for the EU medicine regulatory framework. Clinical Pharmacology and Therapeutics, 100(1), 21-23. https://doi.org/10.1002/cpt.378

Saito J. Yakuwa N. Kaneko K. Takai C. Goto M. Nakajima K. . . . Murashima A. (2019). Tocilizumab during pregnancy and lactation: Drug levels in maternal serum, cord blood, breast milk and infant serum. Rheumatology (Oxford), 58(8), 1505–1507. https://doi.org/10.1093/rheumatology/kez100

Shields K. E. Lyerly A. D. (2013). Exclusion of pregnant women from industry-sponsored clinical trials. Obstetrics & Gynecology, 122(5), 1077–1081. https://doi.org/10.1097/AOG.0b013e3182a9ca67

Stuebe A. M. Meltzer-Brody S. Pearson B. Pedersen C. Grewen K. (2015). Maternal neuroendocrine serum levels in exclusively breastfeeding mothers. Breastfeeding Medicine, 10(4), 197–202. https://doi.org/10.1089/bfm.2014.0164

Svendby H. R. Loland B. F. Omtvedt M. Holmsen S. T. Lagerlov P. (2016). Norwegian general practitioners’ knowledge and beliefs about breastfeeding, and their self-rated ability as breastfeeding counsellor. Scandinavian Journal of Primary Health Care, 34(2), 122–129. https://doi.org/10.3109/02813432.2016.1160632

U.S. Department of Health and Human Services. (2019). Clinical lactation studies: Considerations for study design. guidance for industry (draft May 2019). https://www.fda.gov/media/124749/download

U.S. Food and Drug Administration. (2014). Pregnancy and lactation labeling final rule. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htm

Verstegen R. H. J. Ito S. (2019). Drugs in lactation. Journal of Obstetric and Gynaecological Research, 45(3), 522–531. https://doi.org/10.1111/jog.13899

Victora C. G. Bahl R. Barros A. J. Franca G. V. Horton S. Krasevec J. . . . Rollins N. C. (2016). Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong effect. The Lancet, 387(10017), 475–490. https://doi.org/10.1016/S0140-6736(15)01024-7

Wang J. Johnson T. Sahin L. Tassinari M. S. Anderson P. O. Baker T. E. . . . Yao L. P. (2017). Evaluation of the safety of drugs and biological products used during lactation: Workshop summary. Clinical Pharmacology and Therapeutics, 101(6), 736–744. https://doi.org/10.1002/cpt.676